SCHEMBL5039641

SCHEMBL5039641

CCCCNC(=O)c1cc(-c2csc(C(=O)OCC)n2)n(CCCOC)c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
HPGD P15428 3/20 0.52
MAPT P10636 3/20 0.47
POLB P06746 1/20 0.47
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 2/20 0.40
APAF1 O14727 1/20 0.40
NSD2 O96028 1/20 0.40
GAA P10253 1/20 0.40
THRB P10828 1/20 0.40
CASP1 P29466 1/20 0.40
RECQL P46063 1/20 0.40
BLM P54132 1/20 0.40
CASP7 P55210 1/20 0.40
ATM Q13315 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 2/20 0.39
LMNA P02545 1/20 0.39
CRHBP P24387 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5043762 0.88 ALDH1A1 (0.43) ALDH1A1HPGDMAPTPOLBKMT2A
SCHEMBL5043901 0.85 MAPT (0.45) ALDH1A1HPGDMAPTPOLBKMT2A
SCHEMBL5047164 0.84 POLB (0.49) ALDH1A1HPGDMAPTPOLBKMT2A
SCHEMBL5048628 0.84 HPGD (0.46) ALDH1A1HPGDMAPTPOLBKMT2A
SCHEMBL5046847 0.83 ALDH1A1 (0.49) ALDH1A1HPGDMAPTPOLBKMT2A
SCHEMBL5043763 0.82 ALDH1A1 (0.37) ALDH1A1HPGDMAPTPOLBKMT2A
SCHEMBL5045868 0.82 TSHR (0.39) ALDH1A1HPGDMAPTPOLBKMT2A
SCHEMBL5048647 0.81 ALDH1A1 (0.67) ALDH1A1HPGDMAPTPOLBKMT2A
SCHEMBL5047587 0.80 ALDH1A1 (0.60) ALDH1A1HPGDMAPTPOLBKMT2A
SCHEMBL5046983 0.79 GSK3B (0.41) ALDH1A1HPGDMAPTPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-7135488-B2 Pyrrolyl-thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-14 US disclosed
EP-1583762-A1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP disclosed
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives HOFFMAN-LA ROCHE INC. 2004-07-29 US disclosed
WO-2004060888-A1 NOVEL CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives CNR1, CNR2, NPY1R ALDH1A1 959/4885HPGD 2000/4885MAPT 3334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.